Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions

Molecular Diagnosis & Therapy
April D SorrellJeffrey N Weitzel


Prevalent as an acquired abnormality in cancer, the role of tumor protein p53 (TP53) as a germline mutation continues to evolve. The clinical impact of a germline TP53 mutation is often dramatic and affects the full life course, with a propensity to develop rare tumors in childhood and multiple common cancers of unexpectedly early onset in adulthood. In this article, we review the clinical relevance of germline mutations in the TP53 tumor suppressor gene to current healthcare practice, including the optimal ways to identify patients with Li-Fraumeni syndrome (LFS), to recognize the core cancers associated with LFS, and to develop strategies for early detection of LFS-associated tumors. Several TP53-targeted approaches to improve outcomes in LFS patients are also reviewed. A case report is used to highlight special TP53 testing dilemmas and unique challenges associated with genetic testing decisions in the current age of rapidly advancing genomic technologies.


Mar 15, 1979·Nature·D P Lane, L V Crawford
May 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A B DeLeoL J Old
Jan 15, 1992·American Journal of Epidemiology·L C StrongM A Tainsky
May 20, 1992·Journal of the National Cancer Institute·L MaN F Boyd
Jul 2, 1992·Nature·D P Lane
Aug 5, 1992·Journal of the National Cancer Institute·N F BoydH L Han
Jun 6, 1991·Nature·A J LevineC A Finlay
Nov 1, 1990·Molecular and Cellular Biology·L DillerB Vogelstein
Dec 20, 1990·Nature·B Vogelstein
Sep 1, 1986·The Journal of Experimental Medicine·L J SmithS Benchimol
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·H MasudaM J Cline
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H P KoefflerR A Bosselman
Mar 1, 1988·The Journal of Experimental Medicine·M LübbertH P Koeffler
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·L V CrawfordJ Taylor-Papadimitriou
Jan 1, 1994·Current Biology : CB·T JacksR A Weinberg
Jul 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M HarveyL A Donehower
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R BishopA Kessinger
Jan 1, 1997·British Journal of Cancer·J M VarleyJ M Birch
Apr 29, 1998·Journal of the National Cancer Institute·M HisadaF P Li
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G L ClaymanH Goepfert
Sep 16, 1999·American Journal of Human Genetics·J M VarleyJ M Birch
Jun 23, 2000·British Journal of Cancer·A ChompretJ Feunteun
May 19, 2001·Journal of Medical Genetics·A ChompretC Bonaïti-Pellié
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·R C RibeiroR Sandrini
Apr 12, 2002·Oncogene·Thomas M RippinAlan R Fersht
Sep 20, 2002·The New England Journal of Medicine·Norman F BoydJohn L Hopper
Nov 7, 2002·Reproductive Biomedicine Online·Svetlana RechitskyYury Verlinsky
Jan 23, 2003·Reproductive Biomedicine Online·Yury VerlinskyAnver Kuliev
Mar 1, 2003·American Journal of Human Genetics·Shih-Jen HwangLouise C Strong
Jul 30, 2004·The New England Journal of Medicine·Mieke KriegeUNKNOWN Magnetic Resonance Imaging Screening Study Group
Sep 3, 2004·Journal of Pediatric Hematology/oncology·Smadar AvigadRina Zaizov
Mar 12, 2005·Arquivos brasileiros de endocrinologia e metabologia·Emilia M PintoAna Claudia Latronico

❮ Previous
Next ❯


Jun 19, 2013·Current Treatment Options in Oncology·Alessandro Gronchi, Paolo G Casali
Dec 17, 2014·Current Problems in Cancer·Kimberly King-Spohn, Robert Pilarski
Mar 20, 2014·Nature Reviews. Clinical Oncology·Kate A McBrideGillian Mitchell
Feb 16, 2016·European Journal of Medical Genetics·Kjeld Schmiegelow
Jun 16, 2015·BioMed Research International·Angela TossLaura Cortesi
Dec 17, 2016·British Journal of Haematology·Jessica M ValdezChimene Kesserwan
Mar 31, 2017·Journal of Genetic Counseling·Sarah ScollonKami Wolfe Schneider
May 17, 2017·Familial Cancer·R O'SheaD J Gallagher
Mar 1, 2018·Nature·Susanne N GröbnerStefan M Pfister
Mar 13, 2018·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·M Q ChanA Chak
Dec 1, 2017·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Jeffrey N WeitzelKory Jasperson
May 14, 2019·Minerva medica·Angela TossGiovanni Grandi
Aug 31, 2019·Acta Neuropathologica·Brent A OrrChimene Kesserwan
Nov 7, 2014·Journal of Pediatric Hematology/oncology·Rachael Courtney, Sarangarajan Ranganathan
Apr 8, 2014·Human Mutation·Junne KamiharaJudy E Garber
May 6, 2017·Der Pathologe·C Mawrin
Feb 3, 2019·Cold Spring Harbor Molecular Case Studies·Mahesh SwaminathanCourtney D DiNardo
Sep 9, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Antonella PietragallaAnna Fagotti
Jul 30, 2016·Blood·UNKNOWN University of Chicago Hematopoietic Malignancies Cancer Risk Team
Nov 7, 2019·Molecular and Clinical Oncology·Anja BukovacNives Pećina-Šlaus
Jul 11, 2018·Endocrine-related Cancer·Catherine GoudieWilliam D Foulkes
May 14, 2019·Clinical Genetics·Pedram KharazihaSvetlana Bajalica-Lagercrantz
Dec 31, 2019·Case Reports in Oncological Medicine·Richard A PetersonLeah R Hanson
Nov 12, 2015·Cancer Research·Assunta De RienzoRaphael Bueno
Jun 3, 2021·Cancers·Sebastian Zahnreich, Heinz Schmidberger
Oct 15, 2020·Familial Cancer·Carla EscudeiroManuel R Teixeira
Sep 17, 2021·Journal of Cancer Research and Therapeutics·Yasir Hameed, Samina Ejaz
Oct 19, 2021·Frontiers in Oncology·Yanong LiXiaoguang Qiu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Olaia Aurtenetxe SáezAurora Navajas
Genetics in Medicine : Official Journal of the American College of Medical Genetics
Susan K PetersonLouise C Strong
© 2021 Meta ULC. All rights reserved